AI-generated summary
In a blind, randomized, controlled trial, the authors compared photobiomodulation with placebo in 41 people taking antihypertensive drugs that can reduce saliva. The photobiomodulation group had salivary glands treated weekly for four weeks, and the authors report significant increases in salivary flow in that group compared with placebo. No significant differences were found in pH, protein or calcium concentration.
- Participants
- 41
- Who or what was studied
- Individuals using antihypertensive medications with hyposalivation
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The abstract reports a single trial of 41 subjects over four weeks and does not describe long-term outcomes or the clinical importance of the salivary flow changes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.